Obesity Worsens Alcohol-Associated Hepatitis: More Infections, AKI and Lower Survival: Clinical and Translational Gastroenterology | September 2026

What Did the Study Find?

This analysis included 778 patients with alcohol-associated hepatitis (AH) from the US multicenter AlcHepNet observational cohort and randomized trial; 39.8% had obesity. Pasted text

• Patients with obesity presented with more severe AH, including higher bilirubin, creatinine, INR, MELD and Maddrey discriminant function scores. Pasted text
• Bacterial infection during hospitalization occurred in 41.0% with obesity vs 27.3% overweight and 27.4% normal weight. Pasted text
• After adjustment, obesity remained associated with 84% higher odds of infection within 180 days (OR 1.84).
• The odds of acute kidney injury were more than doubled (OR 2.25).
• Obesity independently predicted worse 180-day survival (HR 1.50).
• Mechanistically, obese patients showed a more pronounced pro-inflammatory cytokine/chemokine profile and lower levels of growth factors. Pasted text

Why Does It Matter?

Alcohol-associated hepatitis is usually risk-stratified according to liver and organ failure severity. These data suggest that obesity adds an important metabolic-inflammatory dimension, potentially amplifying infection, renal dysfunction and mortality.

GastroAGI Takeaway

In alcohol-associated hepatitis, obesity is not merely a background comorbidity—it identifies a higher-risk phenotype. Obese patients had more infection, more AKI and worse 180-day survival, even after adjustment for disease severity. The accompanying inflammatory signature provides biological plausibility for an alcohol–metabolic–immune interaction, although the observational analysis cannot establish that obesity itself causes these adverse outcomes.